US News in Brief, August 6, 2010 06-Aug-2010 Study suggests bias in industry research FDA lifts hold on stem-cell trial New flu shots approved GSK forms two new drug partnerships New recommendations on FDA device reviews  Read more... US News in Brief, July 30, 2010 30-Jul-2010 FDA clears Daiichi hypertension drug Merck Serono MS pill wins priority review Astellas and Regeneron extend deal Counterfeit medicines summit FDA approves drug for drooling Read more... First generic Lovenox approved 29-Jul-2010 In a controversial move, the US Food and Drug Administration has approved for marketing the first generic version of sanofi-aventis’ blockbuster blood-thinner Lovenox (enoxaparin sodium injection), which is indicated for a number of uses, including prevention of deep vein thrombosis Read more... FDA advisors support GSK's Avandia 15-Jul-2010 Members of two advisory committees to the US Food and Drug Administration voted on Wednesday to recommend that the Federal agency allow GlaxoSmithKline’s (GSK) blockbuster diabetes drug Avandia to stay on the market in spite of safety concerns Read more... US News in Brief, July 15, 2010 15-Jul-2010 J&J buys stroke device firm Lilly partners on antiplatelet program New PhRMA CEO Lawmakers say GSK hid data Novartis settles discrimination suit Read more... Are you number 12? 12-Jul-2010 Around the world, 500 million people – one in 12 of the global population – are infected with viral hepatitis B or C and one million people die each year from these diseases. Despite the huge disease burden, and alarming mortality rate, viral hepatitis is still not a priority for many governments and does not garner the media and public attention needed to effect change Read more... Merck closing 16 facilities 12-Jul-2010 Merck is continuing to consolidate its operations following its merger with Schering-Plough, announcing on Thursday that it will close eight R&D facilities and eight manufacturing plants Read more... US News in Brief, July 12, 2010 12-Jul-2010 Lilly to buy biotech company Abbott loses pharma chief Device approved to treat AMD Par Pharma nausea drug approved GSK migraine study fails Read more... A family affair 01-Jul-2010 Alzheimer's disease (AD) is a looming but unrecognized public health crisis in Hispanic/Latino communities, evidenced by a higher incidence and earlier onset of AD in Hispanics versus the general US population Read more... Celgene to buy biotech company 01-Jul-2010 Celgene Corporation has signed an agreement to buy Abraxis BioScience, a biotech firm focused on drug-delivery technology, for approximately $2.9 billion in upfront payments, in addition to potential milestone payments and royalties due to shareholders Read more...

Page  1 2 3